Pityriasis lichenoides et varioliformis acuta-like eruption after brentuximab vedotin treatment for peripheral T-cell lymphoma
European Journal of Dermatology · 2023
DOI: 10.1684/ejd.2023.4494 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Dermatology, 2023. Verfasst von Shin Iinuma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Japanese Red Cross Kitami Hospital, Kitami, Japan, Department of Dermatology, Asahikawa Medical University, Asahikawa, Jap…. Hauptthemen laut MEDLINE: Pityriasis Lichenoides, Lymphoma, T-Cell, Peripheral, Exanthema. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Japanese Red Cross Kitami Hospital, Kitami, Japan, Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.
- Department of Dermatology, Japanese Red Cross Kitami Hospital, Kitami, Japan.
- Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.
Zitieren
APA
Iinuma, S., Kobayashi, T., & Ishida-Yamamoto, A. (2023). Pityriasis lichenoides et varioliformis acuta-like eruption after brentuximab vedotin treatment for peripheral T-cell lymphoma. European Journal of Dermatology. https://doi.org/10.1684/ejd.2023.4494
Vancouver
Iinuma S, Kobayashi T, Ishida-Yamamoto A. Pityriasis lichenoides et varioliformis acuta-like eruption after brentuximab vedotin treatment for peripheral T-cell lymphoma. European Journal of Dermatology. 2023. doi:10.1684/ejd.2023.4494
BibTeX
@article{Iinuma2023,
author = {Iinuma, Shin and Kobayashi, Takahiro and Ishida-Yamamoto, Akemi},
title = {Pityriasis lichenoides et varioliformis acuta-like eruption after brentuximab vedotin treatment for peripheral T-cell lymphoma},
journal = {European Journal of Dermatology},
year = {2023},
doi = {10.1684/ejd.2023.4494}
}
EUVIMED